2 assets in Acute Myeloid Leukemia, FLT3 Tyrosine Kinase Domain Point Mutation

Therapeutic assets addressing Acute Myeloid Leukemia, FLT3 Tyrosine Kinase Domain Point Mutation, rated under Floatz methodology v0.2 and sorted by current rating.